<DOC>
	<DOC>NCT00673205</DOC>
	<brief_summary>The purpose of this trial is to study the effect of adjuvant or immediate hormonal therapy, versus placebo, in subjects who have either undergone a primary therapy (principally radical prostatectomy or radiotherapy) or who were otherwise to be managed by watchful waiting.</brief_summary>
	<brief_title>(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>Clinical diagnosis of nonmetastatic cancer of the prostate gland Patient to be 18 years and above Previous systemic therapy for prostate cancer Previous history of another form of cancer (not prostate) within 5 years of study start.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>androgen antagonists</keyword>
	<keyword>prostate neoplasms</keyword>
</DOC>